Changes to the Code
S. 3522 · No Red Tape For Addiction Treatment Act · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
42 U.S.C. § 1396d Definitions
2 changes the bill asks for here, 2 carried out
- Carried out:
in subsection (a)(29), by striking
(2) and (3)
and inserting(2), (3), and (4)
; and - Carried out:
in subsection (ee), by adding at the end the following new paragraph:
(4) Provision of medication-assisted treatment without prior authorization.— (A) In general.— A State plan (or a waiver of such plan) shall provide coverage of at least 1 formulation of each drug and biological product described in paragraph (1)(A) (which shall include, if …
§ 1396d(a)Medical assistance(28)–(31)
Start of § 1396d to (a)(27) unchanged ·
(28) freestanding birth center services (as defined in subsection (l)(3)(A)) and other ambulatory services that are offered by a freestanding birth center (as defined in subsection (l)(3)(B)) and that are otherwise included in the plan;
(29) subject to paragraphs (2)[inserted: ,] [inserted: (3), ]and ([struck: 3][inserted: 4]) of subsection (ee), beginning on October 1, 2020, medication-assisted treatment (as defined in paragraph (1) of such subsection);
(30) subject to subsection (gg), routine patient costs for items and services furnished in connection with participation in a qualifying clinical trial (as defined in such subsection);
(31) certified community behavioral health clinic services, as defined in subsection (jj); and
§ 1396d(ee)–(ff)
(a)(32)–(ee)(3) unchanged ·
(A) furnished as medical assistance in accordance with subsection (a)(29) and section 1396a(a)(10)(A) of this title; and
(B) a covered outpatient drug (as defined in section 1396r–8(k) of this title, except that, in applying paragraph (2)(A) of such section to a drug described in paragraph (1)(A), such drug shall be deemed a prescribed drug for purposes of subsection (a)(12)).
(4) [inserted: Provision of medication-assisted treatment without prior authorization.—]
(A) [inserted: In general.—] [inserted: A State plan (or a waiver of such plan) shall provide coverage of at least 1 formulation of each drug and biological product described in paragraph (1)(A) (which shall include, if available with respect to such a drug or biological product, a formulation that is long-lasting and injectable) that is not subject to prior authorization or limitations on dosage as a condition of coverage or payment for such drug or biological product.]
(B) [inserted: Rule of construction.—] [inserted: The requirement under subparagraph (A) to provide coverage of at least 1 formulation of each drug and biological product described in paragraph (1)(A) shall not be construed as modifying or limiting the ability of a State to establish a formulary that is consistent with the requirements of section 1927(d)(4).]
(ff) Increase in FMAP for territories for certain fiscal years Notwithstanding subsection (b) or (z)(2), subject to subsections (hh) and (ii)—
(1) for the period beginning October 1, 2019, and ending December 20, 2019, the Federal medical assistance percentage for Puerto Rico, the Virgin Islands, Guam, the Northern Mariana Islands, and American Samoa shall be equal to 100 percent;
Rest of § 1396d unchanged ·
42 U.S.C. § 1396r–8 Payment for covered outpatient drugs
1 change the bill asks for here, 1 carried out
- Carried out:
Section 1927(d)(1)(A) of the Social Security Act (42 U.S.C. 1396r–8(d)(1)(A)) is amended by striking
A State
and insertingExcept as provided in section 1905(ee)(4), a State
.
§ 1396r–8(d)Limitations on coverage of drugs(1)
Start of § 1396r–8 to (c)(4)(D) unchanged ·
(d) Limitations on coverage of drugs
(1) Permissible restrictions
(A) [struck: A][inserted: Except] [inserted: as provided in section 1905(ee)(4), a ]State may subject to prior authorization any covered outpatient drug. Any such prior authorization program shall comply with the requirements of paragraph (5).
(B) A State may exclude or otherwise restrict coverage of a covered outpatient drug if—
(i) the prescribed use is not for a medically accepted indication (as defined in subsection (k)(6));
Rest of § 1396r–8 unchanged ·